ArticleCurrent hematologic malignancy reports2009
The role of gemtuzumab ozogamicin in combination chemotherapy regimens for primary resistant or relapsed acute myeloid leukemia.
Hien K Duong et al.PubMed ↗Publisher ↗
No numbers read from the abstract.